HomeCompareCTCX vs NNN

CTCX vs NNN: Dividend Comparison 2026

CTCX yields 1013.68% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTCX wins by $21217097.10M in total portfolio value
10 years
CTCX
CTCX
● Live price
1013.68%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21217097.13M
Annual income
$17,768,877,895,719.51
Full CTCX calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — CTCX vs NNN

📍 CTCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTCXNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTCX + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTCX pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCX
Annual income on $10K today (after 15% tax)
$86,163.20/yr
After 10yr DRIP, annual income (after tax)
$15,103,546,211,361.58/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, CTCX beats the other by $15,103,546,209,132.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCX + NNN for your $10,000?

CTCX: 50%NNN: 50%
100% NNN50/50100% CTCX
Portfolio after 10yr
$10608548.58M
Annual income
$8,884,438,949,171.09/yr
Blended yield
83.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

CTCX
No analyst data
Altman Z
-56.1
Piotroski
4/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCX buys
0
NNN buys
0
No recent congressional trades found for CTCX or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTCXNNN
Forward yield1013.68%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$21217097.13M$25.5K
Annual income after 10y$17,768,877,895,719.51$2,622.67
Total dividends collected$20954125.95M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CTCX vs NNN ($10,000, DRIP)

YearCTCX PortfolioCTCX Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$112,068$101,368.47$10,735$614.96+$101.3KCTCX
2$1,181,615$1,061,701.90$11,572$708.43+$1.17MCTCX
3$11,726,249$10,461,920.38$12,531$819.53+$11.71MCTCX
4$109,578,123$97,031,037.37$13,633$952.29+$109.56MCTCX
5$964,654,833$847,406,240.94$14,909$1,111.84+$964.64MCTCX
6$8,004,158,004$6,971,977,332.68$16,392$1,304.77+$8004.14MCTCX
7$62,629,410,485$54,064,961,420.43$18,129$1,539.52+$62629.39MCTCX
8$462,375,346,702$395,361,877,482.99$20,173$1,827.08+$462375.33MCTCX
9$3,222,634,793,872$2,727,893,172,901.40$22,597$2,181.81+$3222634.77MCTCX
10$21,217,097,125,163$17,768,877,895,719.51$25,491$2,622.67+$21217097.10MCTCX

CTCX vs NNN: Complete Analysis 2026

CTCXStock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCX Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this CTCX vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCX vs SCHDCTCX vs JEPICTCX vs OCTCX vs KOCTCX vs MAINCTCX vs ADCCTCX vs EPRTCTCX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.